According to Viatris's latest financial reports the company's total liabilities are $27.21 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $27.21 B | -5.98% |
2022-12-31 | $28.94 B | -15.72% |
2021-12-31 | $34.35 B | -11.01% |
2020-12-31 | $38.59 B | 99.25% |
2019-12-31 | $19.37 B | -5.82% |
2018-12-31 | $20.56 B | -8.58% |
2017-12-31 | $22.49 B | -4.7% |
2016-12-31 | $23.60 B | 88.84% |
2015-12-31 | $12.50 B | -0.34% |
2014-12-31 | $12.54 B | 1.7% |
2013-12-31 | $12.33 B | 43.83% |
2012-12-31 | $8.57 B | 5.96% |
2011-12-31 | $8.09 B | 2.17% |
2010-12-31 | $7.92 B | 3.46% |
2009-12-31 | $7.65 B | -0.27% |
2008-12-31 | $7.67 B | -3.01% |
2007-12-31 | $7.91 B | |
2007-03-31 | $2.56 B | 136.57% |
2006-03-31 | $1.08 B | 273.74% |
2005-03-31 | $0.28 B | 28.62% |
2004-03-31 | $0.22 B | -24.63% |
2003-03-31 | $0.29 B | 36.46% |
2002-03-31 | $0.21 B | -34.96% |
2001-03-31 | $0.33 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | -97.71% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $12.52 M | -99.95% | ๐บ๐ธ USA |